This website uses cookies to help us give you the best browsing experience. By continuing to use this portal, you agree to our use of this tool.
To learn more about how we use cookies and how to manage them please read our notice here.
Pearls from the EGS Guidelines
Pearls from the EGS Guidelines
Individualized glaucoma treatment

Publishing date: May 2020

Pearls Manager: Andrew Tatham

Individualized glaucoma treatment aims at providing glaucoma management tailored to the individual needs of the patient; patients with severe functional loss or younger patients with manifest disease should have more aggressive treatment and closer follow up than patients at low risk, e.g. patients with ocular hypertension or elderly patients with mild field loss and low IOP.

EGS Guidelines, 4th edition, Page 133.

Leske MC, Heijl A, Hyman L, et al. Predictors or long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114(11):1965-72.

The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 2002;134 (4):499-512.

back to top